MyStart Health review

Take a quarter dose here and you pay the base rate — MyStart states it in the reader's own terms, and even carves out the one exception. That is the honest part, and so is publishing the standing figure before promotions rather than after, which is the reverse of how this category usually advertises. Give it credit too for admitting that a monthly charge may ship a four-week supply, and for refunding the appointment if you are found ineligible. Two things will cost you if you misread them. Two promotions stack on top of the published rate, one of them permanent, and the resulting monthly figure is never printed — so the number you would actually be charged is not on the site. And the three-month plan has no published price at all, which matters because a refill intake is compulsory every three months whichever plan you are on.

Vs median

$130/mo above the $169 median across the 242 of 373 programs we track that publish a plain monthly rate

Market

$59–$1300/mo is the full published spread in our ranking

Structure

Same price at every dose

Consult

Included in the price

Dietitian

Not included

Labs

Not required

Pricing

Flat at every dose

Price last updated

August 2026

MyStart Health does not publicly identify the pharmacy that fills its prescriptions. No bloodwork is required before you start. A clinician review is included in the price.

MyStart Health sells compounded semaglutide on a monthly or three-month plan, describing itself as "a technology platform that facilitates access to independent third-party healthcare providers and pharmacies" rather than as a clinic. It publishes its standing rate before promotions rather than after, guarantees the rate will not change once you join, and requires a refill intake form every three months whichever plan you are on. It displays a LegitScript seal number. It names no compounding pharmacy, publishes no state list, and sells no tirzepatide. Cancellation is by email or phone rather than from an account.

ONE PRICE AT EVERY DOSE. A patient deliberately holding a quarter dose pays the same base rate as one at the top of the range

• THE RATE MOST NEW PATIENTS WOULD PAY IS NOT PUBLISHED. Two promotions stack — "$150 Off + Lifetime 25% Off" — and the site never prints the resulting monthly figure, so $299 is the only number it commits to
• A monthly charge may ship a four-week supply, which drifts about thirteen days a year against the calendar
• The three-month plan's price is not published at all, and a refill intake is compulsory every three months regardless of plan
• A "Holiday Savings" banner runs in August, so the urgency is decorative
• Cancellation is by email with CANCEL in the subject line, or by phone — no in-account cancellation is described
• Semaglutide only; no tirzepatide is sold
• MyStart describes itself as a technology platform rather than the provider of care, and names neither the pharmacy nor the states it serves
• Compounded GLP-1s are not FDA-approved, and intentional microdosing is off-label and unproven

MyStart Health is one of 373 low-dose GLP-1 programs we track, and 242 of them publish a monthly rate you can read before signing up. The ranking lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.

Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.

• What the evidence actually shows
• What microdosing GLP-1 costs
• Low dose vs full dose
• What a flat price costs at a low dose
• The true annual cost of a plan